The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …

Over the past century, the incidence of inflammatory bowel disease (IBD) in high-income
countries has shown a sharp rise that then plateaued, and a similar trend has been …

Over the past decades, the treatment of inflammatory bowel diseases (IBD) has become
more targeted, anticipating the use of immune-modifying therapies at an earlier stage. This …

Patients with inflammatory bowel disease (IBD) may require different immunosuppressive
treatments throughout their illness. It is essential to assess the immunization status of …

Inflammatory bowel disease (IBD) is generally considered a disease of high-income
countries and is regarded as rare in sub-Saharan Africa. However, this assumption is almost …

Background. The aim of our study was to describe 50 cases of inflammatory bowel disease
(IBD) and HIV co-existence that are under medical supervision in Warsaw. Methods. This …

Abstract Purpose of Review Inflammatory Bowel Disease (IBD) is a chronic GI inflammatory
condition induced by a dysregulated immune system activation, whereas HIV infection …

Los pacientes con enfermedad inflamatoria intestinal (EII) pueden requerir diferentes
tratamientos inmunosupresores a lo largo del curso de su enfermedad. Por ello, es …

Combination antiretroviral therapy (ART) has changed the landscape of the HIV epidemic by
providing an effective means for viral suppression to people living with HIV (PLWH) …

Once an elusive point on the clinical map, the intersection between inflammatory bowel
disease (IBD) and HIV infection is becoming increasingly commonplace, leading to new …